Seneca Biopharma

$1.18
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.08 (+7.21%) Today

-$0.01 (-0.84%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell SNCA and other stocks, options, and ETFs commission-free!

About SNCA

Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD. The listed name for SNCA is Seneca Biopharma, Inc. Common Stock.

CEO

Kenneth C. Carter

Employees

Headquarters

Germantown, Maryland

Founded

1996

Market Cap

23.36M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.43M

High Today

$1.20

Low Today

$1.05

Open Price

$1.09

Volume

2.20M

52 Week High

$2.20

52 Week Low

$0.50

SNCA Earnings

-$1.45

-$0.97

-$0.48

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 25, Pre-Market